SHANGHAI ALLIST PHARMACEUTICALS CO., LTD revenue breakdown overview

SHANGHAI ALLIST PHARMACEUTICALS CO., LTD revenue for the last year amounted to 2.02 B CNY, the most of which — 1.98 B CNY — came from its highest performing source at the moment, Anti-tumor, the year earlier bringing 790.32 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought SHANGHAI ALLIST PHARMACEUTICALS CO., LTD 1.98 B CNY, and the year before that — 790.94 M CNY.